Showing results (2391-2400 of 6,517) with videos related to

Sort By:
Pageof 652
Cancer Immunology, Immunotherapy : CII|February 7, 2001
Microsatellite instability analysis in tumors with different mechanisms for total loss of HLA expressionP Jimenez, J Cantón, A Concha, et al.
Cancer Immunology, Immunotherapy : CII|September 22, 2000
Sequential administration of interferon gamma and interleukin-2 in metastatic renal cell carcinoma: results of a phase II trial. Austrian Renal Cell Carcinoma Study GroupM Schmidinger, G G Steger, C Wenzel, et al.
Cancer Immunology, Immunotherapy : CII|March 22, 2001
Effects of granulocyte-colony-stimulating factor and granulocyte/macrophage-colony-stimulating factor administration on T cell proliferation and phagocyte cell-surface molecules during hematopoietic reconstitution after autologous peripheral blood progenitor cell transplantationA Fattorossi, A Battaglia, L Pierelli, et al.
Cancer Immunology, Immunotherapy : CII|June 13, 2001
Expression of L-selectin and efficient binding to high endothelial venules do not modulate the dissemination potential of murine B-cell lymphomaR Aviram, N Raz, T Kukulansky, et al.
Cancer Immunology, Immunotherapy : CII|June 13, 2001
Human scFv antibody fragments specific for the epithelial tumour marker MUC-1, selected by phage display on living cellsC Wong, R Waibel, M Sheets, et al.
Cancer Immunology, Immunotherapy : CII|November 12, 2019
ISG15 pathway knockdown reverses pancreatic cancer cell transformation and decreases murine pancreatic tumor growth via downregulation of PDL-1 expressionJulian Burks, Alia Fleury, Sarah Livingston, et al.
Cancer Immunology, Immunotherapy : CII|November 6, 2019
Preclinical development of T-cell receptor-engineered T-cell therapy targeting the 5T4 tumor antigen on renal cell carcinomaYuexin Xu, Alicia J Morales, Michael J Cargill, et al.
Cancer Immunology, Immunotherapy : CII|November 7, 2019
Predominance of M2 macrophages in gliomas leads to the suppression of local and systemic immunityAurobind Vidyarthi, Tapan Agnihotri, Nargis Khan, et al.
Cancer Immunology, Immunotherapy : CII|November 7, 2019
Arginase-1-based vaccination against the tumor microenvironment: the identification of an optimal T-cell epitopeEvelina Martinenaite, Shamaila Munir Ahmad, Simone Kloch Bendtsen, et al.
Cancer Immunology, Immunotherapy : CII|February 27, 2020
Prostaglandin E2 in a TLR3- and 7/8-agonist-based DC maturation cocktail generates mature, cytokine-producing, migratory DCs but impairs antigen cross-presentation to CD8+ T cellsPhilipp Gierlich, Veronika Lex, Antje Technau, et al.
Pageof 652